Last edition
News about "clinical development "
Alumis and Kaken Pharmaceutical to Develop ESK-001 in Dermatology in Japan
Under the terms of the agreement, Alumis will receive USD 40 million in upfront and near-term co-development payments from 2025 to 2026, with the potential to earn up to approximately USD 140 million in additional payments based on the achievement of milestones, and field option payments.
Clinical Development | 28/03/2025 | By Aishwarya
Novartis to Acquire Anthos Therapeutics for USD 925 Million Upfront
Anthos Therapeutics, launched by Blackstone Life Sciences and Novartis in 2019, has advanced abelacimab through clinical development under a license from Novartis.
Clinical Development | 12/02/2025 | By Aishwarya
Verismo Therapeutics Completes Merger to Accelerate Clinical Development
The merger will accelerate the clinical development of SynKIR™-110 and SynKIR™-310 for solid tumor and blood cancer patients, respectively, solidifying Verismo's and HLB Group's collective mission to advance its innovative KIR-CAR platform for patients worldwide.
Clinical Development | 21/12/2024 | By Aishwarya | 210
Allink Biotherapeutics Secures USD 42 Million Series A Financing Round
The financing round was led by Lanchi Ventures, a preeminent global early-stage technology investor known for backing breakthrough innovations, with participation from an elite syndicate of new investors.
Clinical Development | 02/12/2024 | By Aishwarya
BioMarin Strengthens its Leadership with New Appointments
At BioMarin, he will assume responsibility for the company's R&D organization, including discovery research, preclinical, translational and clinical programs, as well as global regulatory and medical affairs.
Clinical Development | 22/08/2024 | By Aishwarya | 234
AusperBio Receives USD 37 Million in Series A Financing Round
AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. has announced the completion of a USD 37 million Series A financing round.
Clinical Development | 16/07/2024 | By Aishwarya | 275
Syngene Rolls Out New Platform for Enhanced Protein Production
Syngene International Ltd. has introduced its new protein production platform.
Clinical Development | 05/06/2024 | By Aishwarya | 298
CASI Pharmaceuticals Advances CID-103 into Clinical Development for Chronic Immune Thrombocytopenia
CASI received a letter from the FDA indicating clearance for the study to proceed, signaling regulatory approval for the advancement of CID-103 into clinical trials.
Clinical Development | 16/05/2024 | By Abha | 175
Athira Pharma Announces Appointment of Javier San Martin as Chief Medical Officer
Athira Pharma, Inc. has appointed Javier San Martin, MD, as Chief Medical Officer.
Clinical Development | 16/04/2024 | By Aishwarya | 302
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy